• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在α-突触核蛋白病的基因小鼠模型中,单体α-突触核蛋白的模板化诱导炎症和黑质致密部多巴胺能神经元死亡。

Templating of Monomeric Alpha-Synuclein Induces Inflammation and SNpc Dopamine Neuron Death in a Genetic Mouse Model of Synucleinopathy.

作者信息

Byrne Matthew D, Petramfar Peyman, Lee Jae-Kyung, Smeyne Richard Jay

机构信息

Thomas Jefferson University.

University of Georgia.

出版信息

Res Sq. 2024 Nov 20:rs.3.rs-5269499. doi: 10.21203/rs.3.rs-5269499/v1.

DOI:10.21203/rs.3.rs-5269499/v1
PMID:39606453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11601858/
Abstract

While the etiology of most cases of Parkinson's disease (PD) are idiopathic, it has been estimated that 5-10% of PD arise from known genetic mutations. The first mutations described that leads to the development of an autosomal dominant form of PD are in the SNCA gene that codes for the protein alpha-synuclein (α-syn). α-syn is an abundant presynaptic protein that is natively disordered and whose function is still unclear. In PD, α-syn misfolds into multimeric b-pleated sheets that aggregate in neurons (Lewy Bodies/neurites) and spread throughout the neuraxis in a pattern that aligns with disease progression. Here, using IHC, HC, HPLC, and cytokine analysis, we examined the sequelae of intraparenchymal brain seeding of pre-formed fibrils (PFFs) and monomeric α-syn in C57BL/6J (WT) and A53T SNCA mutant mice. We found that injection of PFFs, but not monomeric α-syn, into the striatum of C57BL/6J mice induced spread of aggregated α-syn, loss of SNpc DA neurons and increased neuroinflammation. However, in A53T SNCA mice, we found that both PFFs and monomeric α-syn induced this pathology. This suggests that the conformation changes in α-syn seen in the A53T strain can recruit wild-type α-syn to a pathological misfolded conformation which may provide a mechanism for the induction of PD in humans with SNCA duplication/triplication.

摘要

虽然大多数帕金森病(PD)病例的病因是特发性的,但据估计,5%-10%的PD由已知基因突变引起。最早描述的导致常染色体显性形式PD发展的突变存在于编码α-突触核蛋白(α-syn)的SNCA基因中。α-syn是一种丰富的突触前蛋白,其天然无序,功能仍不清楚。在PD中,α-syn错误折叠成多聚体β折叠片,聚集在神经元中(路易小体/神经突),并以与疾病进展一致的模式在整个神经轴中扩散。在此,我们使用免疫组织化学(IHC)、高效液相色谱(HPLC)和细胞因子分析,研究了预先形成的原纤维(PFFs)和单体α-syn在脑实质内接种对C57BL/6J(野生型,WT)和A53T SNCA突变小鼠的后遗症。我们发现,向C57BL/6J小鼠纹状体注射PFFs而非单体α-syn,可诱导聚集的α-syn扩散、黑质致密部(SNpc)多巴胺能神经元丢失并增加神经炎症。然而,在A53T SNCA小鼠中,我们发现PFFs和单体α-syn均可诱导这种病理变化。这表明在A53T菌株中看到的α-syn构象变化可将野生型α-syn募集到病理性错误折叠构象,这可能为SNCA重复/三倍体的人类PD诱导提供一种机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/591807186fa1/nihpp-rs5269499v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/830777ba1df7/nihpp-rs5269499v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/0f362445874c/nihpp-rs5269499v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/a4d9a02adaa2/nihpp-rs5269499v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/6f34bdeb8dfa/nihpp-rs5269499v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/70a885f7fea3/nihpp-rs5269499v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/48e011c78d1b/nihpp-rs5269499v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/591807186fa1/nihpp-rs5269499v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/830777ba1df7/nihpp-rs5269499v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/0f362445874c/nihpp-rs5269499v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/a4d9a02adaa2/nihpp-rs5269499v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/6f34bdeb8dfa/nihpp-rs5269499v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/70a885f7fea3/nihpp-rs5269499v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/48e011c78d1b/nihpp-rs5269499v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa4/11601858/591807186fa1/nihpp-rs5269499v1-f0007.jpg

相似文献

1
Templating of Monomeric Alpha-Synuclein Induces Inflammation and SNpc Dopamine Neuron Death in a Genetic Mouse Model of Synucleinopathy.在α-突触核蛋白病的基因小鼠模型中,单体α-突触核蛋白的模板化诱导炎症和黑质致密部多巴胺能神经元死亡。
Res Sq. 2024 Nov 20:rs.3.rs-5269499. doi: 10.21203/rs.3.rs-5269499/v1.
2
Templating of monomeric alpha-synuclein results in inflammation and SNpc dopamine neuron death in a genetic mouse model of induced synucleinopathy.在诱导性突触核蛋白病的基因小鼠模型中,单体α-突触核蛋白的模板化会导致炎症和黑质致密部多巴胺能神经元死亡。
Sci Rep. 2025 Jul 22;15(1):26537. doi: 10.1038/s41598-025-10705-8.
3
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils.携带LRRK2 G2019S的星形胶质细胞通过miR-22-5p表现出簇集蛋白伴侣水平升高,且摄取α-突触核蛋白原纤维的能力降低。
Acta Neuropathol Commun. 2025 May 12;13(1):98. doi: 10.1186/s40478-025-02015-x.
4
Structurally targeted mutagenesis identifies key residues supporting α-synuclein misfolding in multiple system atrophy.结构靶向诱变确定了支持多系统萎缩中α-突触核蛋白错误折叠的关键残基。
J Parkinsons Dis. 2024 Nov;14(8):1543-1558. doi: 10.3233/JPD-240296. Epub 2024 Oct 17.
5
Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.神经元α-突触核蛋白毒性是多系统萎缩中神经退行性变的关键驱动因素。
Brain. 2025 Jul 7;148(7):2306-2319. doi: 10.1093/brain/awaf030.
6
Soluble and Insoluble Lysates from the Human A53T Mutant α-Synuclein Transgenic Mouse Model Induces α-Synucleinopathy Independent of Injection Site.来自人A53T突变α-突触核蛋白转基因小鼠模型的可溶性和不溶性裂解物可诱导α-突触核蛋白病,且与注射部位无关。
Int J Mol Sci. 2025 Jun 28;26(13):6254. doi: 10.3390/ijms26136254.
7
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.α-突触核蛋白寡聚倾向的积累加剧体内突触和神经元的退化。
Brain. 2014 May;137(Pt 5):1496-513. doi: 10.1093/brain/awu057. Epub 2014 Mar 24.
8
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
9
FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson's disease.在帕金森病的神经黑色素 - α-突触核蛋白小鼠模型中,FKBP51抑制可改善神经退行性变和运动功能障碍。
Mol Ther. 2025 Mar 5;33(3):895-916. doi: 10.1016/j.ymthe.2025.01.049. Epub 2025 Feb 3.
10
Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies.联合主动体液和细胞免疫接种方法治疗突触核蛋白病。
J Neurosci. 2018 Jan 24;38(4):1000-1014. doi: 10.1523/JNEUROSCI.1170-17.2017. Epub 2017 Dec 15.

本文引用的文献

1
Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology.帕金森病伴 G2019S LRRK2 突变而无路易体病理。
Mov Disord Clin Pract. 2024 Jul;11(7):874-878. doi: 10.1002/mdc3.14068. Epub 2024 May 16.
2
Synucleinopathies.突触核蛋白病。
Handb Clin Neurol. 2023;196:175-202. doi: 10.1016/B978-0-323-98817-9.00032-6.
3
Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson's disease.
尼可刹米通过抑制坏死性凋亡、神经炎症和α-突触核蛋白寡聚体化,发挥神经保护作用,在亚急性 MPTP 帕金森病小鼠模型中。
Sci Rep. 2023 May 31;13(1):8783. doi: 10.1038/s41598-023-35975-y.
4
⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and Humans.α-突触核蛋白的结构多样性与细胞环境在 α-突触核蛋白传播模型和人类中的作用。
Neurotherapeutics. 2023 Jan;20(1):67-82. doi: 10.1007/s13311-023-01365-5. Epub 2023 Apr 13.
5
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease.炎症小体抑制在进行性帕金森病模型中保护多巴胺能神经元免受α-突触核蛋白病理的影响。
J Neuroinflammation. 2023 Mar 21;20(1):79. doi: 10.1186/s12974-023-02759-0.
6
Mixed pathology as a rule, not exception: Time to reconsider disease nosology.混合病理学是普遍现象,而非例外:是时候重新考虑疾病分类学了。
Handb Clin Neurol. 2023;192:57-71. doi: 10.1016/B978-0-323-85538-9.00012-2.
7
How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review.帕金森病啮齿动物模型对早期非运动表型的模拟效果如何?一项系统评价。
Biomedicines. 2022 Nov 24;10(12):3026. doi: 10.3390/biomedicines10123026.
8
NLRP3 inflammasome in neurodegenerative disease.NLRP3 炎性小体与神经退行性疾病。
Transl Res. 2023 Feb;252:21-33. doi: 10.1016/j.trsl.2022.08.006. Epub 2022 Aug 8.
9
Immune responses in the Parkinson's disease brain.帕金森病大脑中的免疫反应。
Neurobiol Dis. 2022 Jun 15;168:105700. doi: 10.1016/j.nbd.2022.105700. Epub 2022 Mar 18.
10
The Disease Modification Conundrum in Parkinson's Disease: Failures and Hopes.帕金森病中的疾病修饰难题:失败与希望
Front Aging Neurosci. 2022 Feb 28;14:810860. doi: 10.3389/fnagi.2022.810860. eCollection 2022.